Milne, J S (1978). Thorax, 33,[547][548][549][550][551][552][553][554] al, 1973) report studies made exclusively on the elderly. The present paper describes the repetition after one and five years of respiratory function tests in the subjects from one of these studies of the elderly. Details are also given about respiratory symptoms and cigarette smoking at follow-up.
One-quarter of male and one-seventh of female cigarette smokers had given up smoking, mostly in the first year. Nearly all who stopped were symptomless before and after. In those men who stopped smoking before the study began symptom prevalence was similar to that in those who continued smoking.
Mean values of FEV1 and FVC declined as age increased, the decline being greater in FVC with resulting rise in FEV1%. Five-year differences in FEV1 and FVC were symmetrically distributed with mean differences increasing with age. Mean differences in FEV1 were 280-350 ml in men and 150-230 ml in women. Prediction equations from the first examinations remained usable for clinical work. Mean values of FEV1 and FVC at the first examination were smaller in those who died compared with survivors, whether symptoms were present or not. The prevalence of symptoms was greater in those who died.
Several publications report data from population studies of respiratory function (Needham et al, 1954; Kory et al, 1961; Berglund et al, 1963; Ferris et al, 1965; Morris et al, 1973) , but information in these about the elderly tends to be derived from a few subjects in series covering large age ranges. A few papers (Milne and Williamson, 1972(b) ; Schmidt et al, 1973) report studies made exclusively on the elderly. The present paper describes the repetition after one and five years of respiratory function tests in the subjects from one of these studies of the elderly. Details are also given about respiratory symptoms and cigarette smoking at follow-up.
Subjects
The people studied in the first examination were 215 men and 272 women aged 62-90 years who in 1968 formed a simple random sample of the population of 27 000 people in that age range living in ten city wards in north Edinburgh. The method of sampling with a comparison of respondents and non-respondents has been described elsewhere (Milne et al, 1971) . After the first examinations in 1968 and 1969 further examinations were made after one (1969/70) and five (1973/4) years. At the five-year examination it was possible to reexamine 113 men and 148 women. Information from these patients only has been used in analysing longitudinal data. During the five years 78 men and 60 women had died which left 24 men and 64 women surviving who for various reasons were not re-examined. Follow-up of the sample has been described in detail elsewhere (Milne and Chopin, 1975) .
Methods
Subjects were questioned with the MRC questionnaire on respiratory symptoms (1965) at the first examination (1968/9) . The questions were asked 547 J S Milne again at the five-year review (1973/4) . At the first examination smoking habits were studied in detail (Milne and Williamson, 1972(a) ), but at the oneyear and five-year reviews subjects were asked only whether they still smoked cigarettes and if so, how many a day. The reproducibility of the questionnaires was tested before the survey began (Milne et al, 1970) .
The respiratory function tests were the forced expiratory volume in one second (FEV1) and the forced vital capacity (FVC) performed on a Vitalograph spirometer. This instrument was reported suitable by Drew and Hughes (1969) for measuring FEV1 and FVC in population studies of normal subjects and of those with obstructive airways disease. Tests were performed with subjects sitting, and the best of three readings was used in the analysis. Height was measured with a Harpenden stadiometer. Reproducibility of the tests and calibration of the Vitalograph were satisfactory and have been reported elsewhere (Milne and Williamson, 1972(b) One-quarter of the men and just over oneseventh of the women who admitted smoking cigarettes at the original examination gave up during the five years. Eleven of 14 men who stopped smoking during the five years gave up after one year, the corresponding figures in women being three of four.
There were no significant age differences in the incidence figures, which were therefore reported separately only by sex.
Stopping smoking during the five years of the study showed little effect on symptoms since 13 of 14 men and all four women who stopped during the period did not have persistent cough and Values of FEV1 % were compared in members of the original sample who died or survived during five years. There being no age effect with this variable, division was by sex only. In men the mean value in those who died (63f3 SE 1-9 N 76) was significantly less than that in survivors . The mean value in women who died (76-9 SE 2 2 N 44) was less than in surviving than such values in corresponding groups o-f the original study, the sizes of the standard errors of Zerences in estimate suggest that the prediction equations from the original study (Milne and Williamson, 1972(b) ) FEV1, FVC, might still be valid for clinical work.
ined in men i of the five-Discussion, NS=notsignificant; *p<0-05; **p<0-01; ***p<0-001.
age increased, in values for respiratory function tests described by Fletcher and Peto (1977) . Prediction equations based on data from the five-year review did not differ significantly from the original equations (table 5) . The exception was the coefficient of regression of FEV1 on age in men, which was significant at the five-year but not at the original examination. The prediction equations of Schmidt et al (1973) produce values greater than those recorded in the first examination in the present study, but the size of the standard errors of estimate in the present study (table 5) means the differences are less than at first sight.
A study from Sweden (Wilhelmsen et al, 1969) reported five-year differences of 330 ml in vital capacity and 230 ml in FEV1 in men aged 50 at entry to their study. These differences are smaller than those in older men in the present study, which has, however, shown that the differences increase with increasing age at entry. Other studies in industry (Higgins et al, 1968 , Howard, 1970 have reported differences in FEVo.75 after five years. These results are not directly comparable with those from the present study but are of the same order of size. Cotes (1968) quotes a mean loss of FEV1 with age in men of 300 ml per decade. The symmetrical distribution of differences in FEV1 over six months in the study of Fletcher and Peto (1977) caused these authors to think that sudden large irreversible falls in FEV1 were rare. The distributions of one-and five-year differences in the present study were also symmetrical.
In the present study the decline in FEV1 and FVC increased with increasing age. This finding is in agreement with the work of Fletcher and Peto. Howard (1970) reported a similar age effect on FEV1 and FVC changes and that FVC fell more in a given time than FEV1. He thought this was due to the greater size of FVC compared with FEV1 and noted little change in FEV1%. The present study showed a similar greater fall with a corresponding increase in FEV1%, which was statistically significant and of the order of 3% (table 4).
Howard thought that the variation in the rate of decline of FEV1 in individuals meant that the normal population without symptoms included subjects in whom the FEV1 was declining rapidly. Hence the "normal" regression coefficient in prevalence studies could be too high. Recent work by Fletcher and Peto has shown that FEV1 declines more rapidly as time passes in cigarette smokers than in non-smokers and that such smokers need not have symptoms. Higgins and Oldham (1962) found, in men aged 20-69 years, that the decline did not vary with age.
A ten-year follow-up of civil servants with chronic bronchitis (Oswald et al, 1967) showed that dyspnoea was the symptom that best estimated prognosis. The death rate in that study rose as the degree of dyspnoea at the original examination increased. The severer grades of dyspnoea were the symptom most likely to be associated with death in the present study.
Changes in symptom prevalence over a period are difficult to explain. Sharp et al (1973) in a seven-year longitudinal study of middle-aged men, in which the MRC questionnaire on respiratory 554 symptoms was used, found that symnptom prevalence recorded at the start declined during the period of study. The original proportions of those with cough and phlegm and of those who smoked cigarettes fell during the seven years. This was true of cough and phlegm in men more than in women in the present study, while the proportion who smoked declined in both sexes. Dyspnoea worse than grade 2 tended to disappear in a greater proportion of women compared with men (table 1) .
With respect to incidence of symptoms in men during the period of study, Sharp et al found that 6-6% of their men developed cough and phlegm and 16 5% developed dyspnoea during seven years, the corresponding figures during five years in the present study being 7 1% and 13%.
Many subjects in the present study who appear as non-smokers at the first and at the five-year examinations (30 of 55 men and 13 of 113 women in table 1) had once smoked cigarettes but stopped before the study began. The relatively small numbers who stopped during the study (14 men, 4 women) made it difficult to assess the effect of stopping. Fletcher and Peto in their eight-year longitudinal study of working men in London were able to separate the effect of smoking in increasing the rate of decline of FEV1 with age from its effect in producing the syndrome of persistent cough and phlegm. The design of the present study and the possibly inaccurate information gathered about when smoking had ceased before the study began made it impossible to use the present study to describe such separation. This study was supported by a grant from the Secretary of State for Scotland.
